Eterna TherapeuticsERNA
Market Cap: $6.82M
About: Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.
Employees: 8
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0.35% less ownership
Funds ownership: 7.57% [Q1] → 7.21% (-0.35%) [Q2]
13% less funds holding
Funds holding: 23 [Q1] → 20 (-3) [Q2]
27% less capital invested
Capital invested by funds: $982K [Q1] → $712K (-$270K) [Q2]
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Research analyst outlook
We haven’t received any recent analyst ratings for ERNA.